Navigation Links
VIASPACE Chairman and CEO Attend EUEC 2013, Giant King Grass Prominently Featured in Convention Exhibit Hall
Date:2/4/2013

e competing products in the bioenergy universe, but we are moving fast to make GKG the preferred platform product because its extremely high yield makes more economic sense than its competitors."

Question: When will VIASPACE be profitable?

Answer: Dr. Schewe responded, "This Company has never been run leaner than its current overhead structure. Both our CEO and CFO took one-third salary pay-cuts on October 1, 2012 when VIASPACE became a stand-alone company. I personally have not drawn a salary for all the work that I have done for the Company. Our other employees work as independent contractors and we rigorously control those costs. All that said, given the number and significance of the deals in our pipeline, I personally believe that we can achieve profitability in 2014."

Question: Is our common stock (VSPC) headed for a reverse split?

Answer: Dr. Schewe responded, "There are no plans for a reverse split this year or in the near future. I currently hold just north of 130,000,000 common VSPC shares and I purchased each and every one of those shares with my hard-earned money. I purchased more than half of those shares on the open market and the rest at a 20% discount to the prior month's average trading price according to my formal agreement to assist in funding the ongoing operations of the Company. I believe that VIASPACE is somewhat unique among penny stocks at this time because the Chairman of the Board wasn't given his stock or awarded his stock in exchange for his work, advice or expertise--he personally paid for it and looks at the stock's value appreciation as does any other common shareholder. If we had adequate corporate revenues at this very moment, my philosophy would be to use that revenue for continued organic corporate growth and to institute a formal share buy-back plan and retire those common shares as we buy them back to decrease the overall share count. Both actions would work together to significantly i
'/>"/>

SOURCE VIASPACE Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. California Healthcare Institute Appoints Allergan CEO Chairman of the Board, Elects New Board Members
2. National Press Club Celebration of the Publication of "The Grace of Stem Cells" by Jeong Chan Ra, Chairman of RNL BIO
3. The Acta Materialia Inc Announces New Chairman of the Board of Governors
4. Althea Technologies Appoints Dr. Dennis Fenton As Chairman Of Its Scientific Advisory Board
5. College Chairman And Prolific Inventor Develops Life-Saving, Real-Time Diagnostic Technologies
6. Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
7. Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara
8. China Biologic Products Names Chairman David Gao to Additional Post of CEO
9. Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman
10. Alliance for Safe Biologic Medicines Chairman Urges FDA to Ensure that Patient Safety is the Cornerstone of Biosimilar Pathway
11. CardioInsight Announces Appointment of Jim Bullock as Chairman of the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ENGLEWOOD, Colo. , Sept. 2, 2015 ... focused on developing treatments for urological and related conditions, ... of its planned private placement convertible note financing, raising ... two prior tranches totaling $3.175 million. ... stated, "Proceeds from this private placement are intended to ...
(Date:9/2/2015)... , September 2, 2015 ... BOLT) ("BioLight" or the "Company"), a firm that ... ophthalmology and cancer diagnostics, announced today that presentations ... glaucoma will be delivered at the Ophthalmology Futures ... European Society of Cataract & Refractive Surgeons ("ESCRS"), ...
(Date:9/2/2015)... , September 2, 2015 ... Gewinner des Wettbewerbs BeHEARD von 2015 bekanntgeben zu ... vom Rare Genomics Institute. Biovista unterstützt ... Medikamenten für die Behandlung anderer Krankheiten als denen, ... Steven Laffoon und sein Team bei der ...
(Date:9/2/2015)... ... September 02, 2015 , ... Whitehouse Laboratories is excited ... Pharma Ed Resources upcoming educational seminar and training session on Extractable & Leachable ... conference will provide Updates & Case Studies on the Latest Compliance Implications of ...
Breaking Biology Technology:Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3
... 23 Keryx Biopharmaceuticals,Inc. (Nasdaq: KERX ) ... The,Nasdaq Stock Market ("Nasdaq") stating that Nasdaq Marketplace ... bid price of,$1.00 per share, has been temporarily ... that it now has until January 23, 2009, ...
... - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) ... I Trial,of Oncolytic Reovirus (REOLYSIN(R)) in Combination ... will be,available in the November/December issue of ... the International Society for Biological Therapy of,Cancer ...
... Oct. 23 MedImmune today announced,that researchers will ... the Annual Meeting of the American College of ... Moscone Center in San Francisco, California., "MedImmune ... for patients,struggling with systemic autoimmune rheumatic diseases," said ...
Cached Biology Technology:Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period 2Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting 3MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology 2MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology 3
(Date:8/26/2015)... , August 26, 2015 The ... and Five Factor), Application (Travel & Immigration, Government, Banking, ... Global Forecast to 2020", published by MarketsandMarkets, Multi-Factor Authentication ... 2020, growing at a CAGR of 17.7% between 2015 ... 82 F igures spread through 169 ...
(Date:8/20/2015)... 2015 The wearable technology market has ... and healthy. However, wearable technology has the potential ... help improve diagnostic capabilities and therapeutic outcomes. Today, ... Wearable Technologies Conference 2015 , where Barrett ... in healthcare.    "Over the past ...
(Date:8/18/2015)... 18, 2015  Navitas today announced that ... the Submission Content Management webinar scheduled on ... forum. Dedicated to the Implementation of Regulatory Submission ... for industry, vendors, health authorities, consultants and ... towards a standard method of implementing electronic ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3
... markers are an indispensable tool for researchers working with ... destroy the function and structure of DNA when inserted. ... be detected in the hereditary material. So researchers have ... at the University of Copenhagen has developed a tool ...
... CT scans to measure blood flow in the lungs of ... smokers are most at risk of emphysema before the disease ... a University of Iowa study. The study found that ... have normal lung function, have very different blood flow patterns ...
... biologist Claire Williams boards ferries bound for North Carolina,s Outer ... captains call her the "Pollen Lady." Each spring ... the islands to the mainland, collecting pine pollen blown far ... loblolly pine the most commonly planted tree in the ...
Cached Biology News:New tool developed for DNA research 2New test could identify smokers at risk of emphysema 2Gone with the wind: Far-flung pine pollen still potent miles from the tree 2
Collected from sexually matured, mixed breed, mixed sex guinea pigs....
Enables rapid purification of double-stranded DNA fragments = 200 bp, including, for example, PCR reaction products, DNA fragments obtained in restriction enzyme digests, or double-stranded cDNA...
...
BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-MSC 2 x 109 cells...
Biology Products: